Results

Total Results: 1,070 records

Showing results for "analyzing".

  1. effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-250-cannabis-2024-surv-rep-update-tables-e1-4.xlsx
    January 01, 2024 - E-1. Can. Study Characteristics Table E-1. Cannabis RCTs study characteristics PMID Author, Year Study Design Crossover Design Enriched Enrollment Randomized Withdrawal Design Setting Pain Population Pain Condition Prior Cannabis Exposure Age Measure (Mean, Median) Age, Years Female % Race, White % Race, Black % Race…
  2. effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-e-surv-report-3-nonopioid-pharmacol-chronic-pain.xlsx
    October 08, 2025 - NPP Table E-1. Neuropathic pain study characteristics Author, Year Country Trial Type Quality Rating Type(s) of Pain Demographics Other Population Characteristics N Randomized N Analyzed Intervention Duration (Weeks) Funding Source Hussain, 2021 Pakistan Placebo-controlled Fair NPP (DPN) Age, mean: 45 Female: 0% R…
  3. effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-250-cannabis-2025-surv-rep-update-tables-e1-4.xlsx
    January 01, 2025 - E-1. Can. Study Characteristics Table E-1. Cannabis RCTs study characteristics PMID Author, Year Study Design Crossover Design Enriched Enrollment Randomized Withdrawal Design Setting Pain Population Pain Condition Prior Cannabis Exposure Age Measure (Mean, Median) Age, Years Female % Race, White % Race, Black % Race…
  4. effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-270-bimp-disposition-comments.pdf
    September 18, 2024 - Evidence-based Practice Center Systematic Review Protocol Comparative Effectiveness Review Disposition of Comments Report Title: Behavioral Interventions for Migraine Prevention Draft report available for public comment from September 5, 2023, to October 20, 2023. Citation: Treadwell…
  5. effectivehealthcare.ahrq.gov/sites/default/files/estimation-and-reporting_chapter-3.pptx
    January 01, 2013 - analysis) To predict whether an individual might benefit from a treatment (predictive learning) Goals for Analyzing … Heterogeneity of Treatment Effect Goals for Analyzing Heterogeneity of Treatment Effect Analyses
  6. effectivehealthcare.ahrq.gov/sites/default/files/related_files/search-strategy-white-paper.pdf
    February 01, 2025 - While not useful for analyzing an existing search per se, it does provide some context of drugs, topics
  7. effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-d-opioid-chronic-pain-surveillance-report-2.xlsx
    September 30, 2015 - Appendix Table D-1. RCTs Table D-1. Randomized controlled trials Author, Year Study Design Duration Setting Country Eligibility Criteria Interventions Sample Characteristics Screened Eligible Randomized Analyzed Results Adverse Events and Withdrawals Due to Adverse Events Sponsor Quality Hruschak, 2021 RCT Duration:…
  8. effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-d-opioid-chronic-pain-surveill-report-1.xlsx
    September 30, 2015 - Appendix Table D-1. RCTs Table D-1. Randomized controlled trials Author, Year Study Design Duration Setting Country Eligibility Criteria Interventions Sample Characteristics Screened Eligible Randomized Analyzed Results Adverse Events and Withdrawals Due to Adverse Events Sponsor Quality Hruschak, 2021 RCT Duration:…
  9. effectivehealthcare.ahrq.gov/sites/default/files/related_files/cancer-anemia-update_executive.pdf
    April 01, 2013 - 1 Epoetin and Darbepoetin for Managing Anemia in Patients Undergoing Cancer Treatment: Comparative Effectiveness Update Executive Summary Background Anemia, a deficiency in the concentration of hemoglobin-containing red blood cells, is prevalent among cancer patients, depending on the type of malignancy and t…
  10. effectivehealthcare.ahrq.gov/sites/default/files/related_files/glaucoma-screening-apendices-11-5-10.pdf
    December 23, 2009 - Appendix A2: FDA status of medical devices for glaucoma screening APPENDIX A FDA STATUS- SCREENING DEVICES SE: Substantially equivalent; Premarket notification, 501(k) Page 1 of 19 Ophthalmoscope, AC-powered Product code: HLI COMPANY PRODUCT FDA STATUS* APPROVAL DATE ACCUTECH MEDICAL TECHNOLOGIES IN…
  11. effectivehealthcare.ahrq.gov/sites/default/files/glaucoma_screening-apendices-11-5-10.pdf
    December 23, 2009 - Appendix A2: FDA status of medical devices for glaucoma screening APPENDIX A FDA STATUS- SCREENING DEVICES SE: Substantially equivalent; Premarket notification, 501(k) Page 1 of 19 Ophthalmoscope, AC-powered Product code: HLI COMPANY PRODUCT FDA STATUS* APPROVAL DATE ACCUTECH MEDICAL TECHNOLOGIES IN…
  12. effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-d-opioid-chronic-pain-surveillance-report-3.xlsx
    September 30, 2015 - Appendix Table D-1. RCTs Table D-1. Randomized controlled trials Author, Year Study Design Duration Setting Country Eligibility Criteria Interventions Sample Characteristics Screened Eligible Randomized Analyzed Results Adverse Events and Withdrawals Due to Adverse Events Sponsor Quality Hruschak, 2021 RCT Duration:…
  13. effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-results-search-strategies-developed-with-without-text-mining-tools.pdf
    March 01, 2021 - set and comparator set, development of the search strategy with references from the development set (analyzing
  14. effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-d-surv-report-3-noninvasive-nonpharma_0.xlsx
    January 01, 2022 - Title Appendix D. Evidence Table Table D-1. Evidence Table Table D-1. Evidence table for new trials included in surveillance reports for noninvasive nonpharmacological treatment for chronic pain report Author, Year Country Number of Centers and Setting Inclusion/Exclusion Criteria Number …
  15. effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-d-surv-report-2-noninvasive-nonpharma.xlsx
    January 01, 2021 - Title Appendix D. Evidence Table Table D-1. Evidence Table Table D-1. Evidence table for new trials included in Surveillance Report 1 for noninvasive nonpharmacological treatment for chronic pain report Author, Year Country Number of Centers and Setting Inclusion/Exclusion Criteria Number…
  16. effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-d-surv-report-1-noninvasive-nonpharma_0.xlsx
    January 01, 2021 - Title Appendix D. Evidence Table Table D-1. Evidence Table Table D-1. Evidence table for new trials included in Surveillance Report 1 for noninvasive nonpharmacological treatment for chronic pain report Author, Year Country Number of Centers and Setting Inclusion/Exclusion Criteria Number…
  17. effectivehealthcare.ahrq.gov/sites/default/files/related_files/gastric-cancers-protocol.pdf
    January 01, 2024 - how treatment effects vary by cancer and demographic subgroups for KQs 2 and 3, we will prioritize analyzing … multiple studies evaluating similar comparisons and subgroups report this data, we will consider meta- analyzing … Key Informants are not involved in analyzing the evidence or writing the report.
  18. effectivehealthcare.ahrq.gov/sites/default/files/related_files/gastric-cancers-protocol-amended.pdf
    February 07, 2025 - how treatment effects vary by cancer and demographic subgroups for KQs 2 and 3, we will prioritize analyzing … multiple studies evaluating similar comparisons and subgroups report this data, we will consider meta- analyzing … Key Informants are not involved in analyzing the evidence or writing the report.
  19. effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-g-surv-report-1-nonopioid-pharmacol-chronic-pain.xlsx
    October 08, 2025 - RCTs Table G-1. Quality assessments of included randomized controlled trials Author, Year Randomization Adequate Allocation Concealment Adequate Patients and Personnel Masked Outcome Assessors Masked Groups Similar at Baseline Intent-to-Treat Analysis (at Least 95% Analyzed) Attrition <20%; Difference Between Groups …
  20. effectivehealthcare.ahrq.gov/sites/default/files/diabetic-neuropathy-disposition-170707.pdf
    March 24, 2017 - When analyzing newer studies to add to the analysis of Griebeler et al, it appears that these newer … We are no longer analyzing anticonvulsants together as a drug class, but are only analyzing comparison

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: